Click here to access this webinar on demand.

Join us for a CLE that will provide an overview of US FDA authorities and regulatory programs applied to cannabis-derived products. The discussion will focus on cannabis in drug development and FDA guidance and resources for cannabis research to support health claims for marketing cannabis-derived products.

*This CLE program is not intended to provide legal advice or establish attorney-client relationships regarding cannabis.


CLE points
1.00 General credit hour pending in CA/DE/GA/NC/SC/TX/VA